These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2360814)

  • 1. Therapeutic studies of cefepime (BMY 28142) in murine meningitis and pharmacokinetics in neonatal rats.
    Tsai YH; Bies M; Leitner F; Kessler RE
    Antimicrob Agents Chemother; 1990 May; 34(5):733-8. PubMed ID: 2360814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.
    Fuchs PC; Jones RN; Barry AL; Thornsberry C
    Antimicrob Agents Chemother; 1985 May; 27(5):679-82. PubMed ID: 3893316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci.
    Kim KS; Bayer AS
    Antimicrob Agents Chemother; 1985 Jul; 28(1):51-4. PubMed ID: 3899006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics.
    Kessler RE; Bies M; Buck RE; Chisholm DR; Pursiano TA; Tsai YH; Misiek M; Price KE; Leitner F
    Antimicrob Agents Chemother; 1985 Feb; 27(2):207-16. PubMed ID: 3885849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion of 3-quaternary ammonium cephem antibiotics into cerebrospinal fluid of patients with bacterial meningitis.
    Modai J
    J Chemother; 1996 Feb; 8 Suppl 2():83-90. PubMed ID: 8738850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cephalosporins in the treatment of bacterial meningitis in adults. Overview with special emphasis on ceftazidime.
    Norrby SR
    Am J Med; 1985 Aug; 79(2A):56-61. PubMed ID: 3895919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
    Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
    Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefepime: overview of activity in vitro and in vivo.
    Grassi GG; Grassi C
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():87-94. PubMed ID: 8150771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and bacteriological effect of ceftazidime in experimental Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli meningitis.
    Sakata Y; Boccazzi A; McCracken GH
    Antimicrob Agents Chemother; 1983 Feb; 23(2):213-7. PubMed ID: 6340600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits.
    Täuber MG; Hackbarth CJ; Scott KG; Rusnak MG; Sande MA
    Antimicrob Agents Chemother; 1985 Mar; 27(3):340-2. PubMed ID: 3838872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of pathogenic bacteria and drug resistance in neonatal purulent meningitis].
    Zhu M; Hu Q; Mai J; Lin Z
    Zhonghua Er Ke Za Zhi; 2015 Jan; 53(1):51-6. PubMed ID: 25748405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro activity of first, second and third generation cephalosporins.
    Forsgren A
    Acta Pathol Microbiol Scand B; 1981 Aug; 89(4):221-5. PubMed ID: 6274143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
    McCracken GH; Nelson JD; Grimm L
    Antimicrob Agents Chemother; 1982 Feb; 21(2):262-7. PubMed ID: 6280599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity of BMY-28142, a novel broad-spectrum cephalosporin.
    Tomatsu K; Ando S; Masuyoshi S; Hirano M; Miyaki T; Kawaguchi H
    J Antibiot (Tokyo); 1986 Nov; 39(11):1584-91. PubMed ID: 3539901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cephalosporins in the treatment of meningitis.
    Neu HC
    Drugs; 1987; 34 Suppl 2():135-53. PubMed ID: 3319497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Phillips I; Warren C; Shannon K; King A; Hanslo D
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of cefprozil (BMY 28100) and cefepime (BMY 28142) against Streptococcus pneumoniae, Branhamella catarrhalis, and Haemophilus influenzae, and provisional interpretive criteria for disk diffusion and dilution susceptibility tests with Haemophilus influenzae.
    Doern GV; Vautour R
    Diagn Microbiol Infect Dis; 1992; 15(7):633-40. PubMed ID: 1424521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.
    Schaad UB; McCracken GH; Loock CA; Thomas ML
    J Infect Dis; 1981 Feb; 143(2):156-63. PubMed ID: 6260870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.